| Stage | USPH | % of rev | EPAC | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $214M | 100.00% | $186M | 100.00% | USPH ×1.15 |
| Gross profit | $87M | 40.43% | $87M | 47.07% | EPAC +6.6pp |
| Operating income | $22M | 10.25% | $34M | 18.48% | EPAC +8.2pp |
| Pre-tax income | $19M | 8.90% | $31M | 16.76% | EPAC +7.9pp |
| Net income | $15M | 6.96% | $24M | 13.17% | EPAC +6.2pp |
| Stage | USPH | EPAC | Gap · A − B |
|---|---|---|---|
| Revenue | $214M100.00% | $186M100.00% | USPH ×1.15 |
| Gross profit | 40.43%$87M | 47.07%$87M | EPAC +6.6pp |
| Operating income | 10.25%$22M | 18.48%$34M | EPAC +8.2pp |
| Pre-tax income | 8.90%$19M | 16.76%$31M | EPAC +7.9pp |
| Net income |
| 6.96%$15M |
| 13.17%$24M |
| EPAC +6.2pp |
No disclosed counterparties: EPAC.
None